- Home
- SNT vs VRCA Comparison
SNT vs VRCA Comparison
Compare SNT & VRCA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SNT | VRCA |
|---|---|---|
| Founded | 1965 | 2013 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Telecommunications Equipment | Biotechnology: Pharmaceutical Preparations |
| Sector | Telecommunications | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 87.5M | 87.5M |
| IPO Year | 2023 | 2018 |
Fundamental Metrics
Financial Performance| Metric | SNT | VRCA |
|---|---|---|
| Price | $2.96 | $4.36 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $17.00 |
| AVG Volume (30 Days) | 17.9K | ★ 120.8K |
| Earning Date | 04-22-2026 | 03-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $35,577,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $92.12 |
| P/E Ratio | $19.22 | ★ N/A |
| Revenue Growth | N/A | ★ 370.22 |
| 52 Week Low | $2.57 | $0.39 |
| 52 Week High | $5.34 | $9.82 |
Technical Indicators
Market Signals| Indicator | SNT | VRCA |
|---|---|---|
| Relative Strength Index (RSI) | 29.41 | 31.13 |
| Support Level | $2.75 | $3.96 |
| Resistance Level | $4.54 | $4.87 |
| Average True Range (ATR) | 0.16 | 0.59 |
| MACD | 0.01 | -0.13 |
| Stochastic Oscillator | 3.82 | 5.40 |
Price Performance
Historical ComparisonAbout SNT Senstar Technologies Ltd.
Senstar Technologies Corp is a provider of comprehensive physical, video, and access control security products and solutions. Its perimeter intrusion detection systems (including fence sensors, buried sensors, and above-ground sensors), intelligent video management, video analytics, and access control offer a comprehensive suite of integrated solutions that reduce complexity, improve performance, and unify support.
About VRCA Verrica Pharmaceuticals Inc.
Verrica Pharmaceuticals Inc is a dermatology therapeutics company engaged in the development and commercialization of novel treatments that provide a meaningful benefit for people living with skin diseases. Its product candidate, VP-102, is developed for the treatment of molluscum contagiosum, or molluscum, a contagious and pediatric viral skin disease, and common warts.